XIN [Xinyuan Real Estate] 6-K: (Original Filing)

[Xinyuan Real Estate Co., Ltd. Announces Third Quarter 2015 Financial Results 3Q15 Contract Sales Up 84.7% YoY to US$309.7 Million 3Q15 Total GFA Sales Up 132.6% YoY to 233,300 Square Meters 3Q15 Net Income Up 609.4% YoY to US$22.7 Million BEIJING, China, November 13, 2015 Third Quarter 2015 Highlights · Total third quarter revenue increased by 88.9% to US$309.0 million] []

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Third Quarter Financial Results -- Conference call scheduled for Thursday, November 12, 2015 at 8:00 AM ET -- BEIJING, November 11, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter and nine month financial results for the period ended September 30, 2015. Third Quarter] []

By | 2016-03-16T06:10:31+00:00 November 13th, 2015|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

XIN [Xinyuan Real Estate] 6-K: Xinyuan Real Estate Co., Ltd. Announces Third Quarter

[Xinyuan Real Estate Co., Ltd. Announces Third Quarter 2015 Financial Results 3Q15 Contract Sales Up 84.7% YoY to US$309.7 Million 3Q15 Total GFA Sales Up 132.6% YoY to 233,300 Square Meters 3Q15 Net Income Up 609.4% YoY to US$22.7 Million BEIJING, China, November 13, 2015 Third Quarter 2015 Highlights · Total third quarter revenue increased by 88.9% to US$309.0 million] []

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Third Quarter Financial Results —

[Sinovac Reports Unaudited Third Quarter Financial Results -- Conference call scheduled for Thursday, November 12, 2015 at 8:00 AM ET -- BEIJING, November 11, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter and nine month financial results for the period ended September 30, 2015. Third Quarter] []

By | 2016-03-16T06:11:28+00:00 November 13th, 2015|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: (Original Filing)

[29 October 2015 Golden Meditech Holdings Limited 48 th 1 Garden Road Central Hong Kong Dear Sirs, Purchase Agreement dated 8 May 2015 relating to the Sale Shares and Note (“the Purchase Agreement”) We refer to the Purchase Agreement. Defined terms used in the Purchase Agreement are also used in this Letter Agreement. In accordance with Clause 3.1 of the] []

By | 2016-03-27T08:11:07+00:00 November 13th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: 29 October 2015 Golden Meditech Holdings Limited 48

[29 October 2015 Golden Meditech Holdings Limited 48 th 1 Garden Road Central Hong Kong Dear Sirs, Purchase Agreement dated 8 May 2015 relating to the Sale Shares and Note (“the Purchase Agreement”) We refer to the Purchase Agreement. Defined terms used in the Purchase Agreement are also used in this Letter Agreement. In accordance with Clause 3.1 of the] []

By | 2016-03-27T08:11:59+00:00 November 13th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar